Literature DB >> 2472035

Bleomycin-induced pulmonary fibrosis in a patient with rheumatoid arthritis. A possible synergistic effect?

M L Aitken, C Dugowson, R A Schmidt, M Fer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2472035      PMCID： PMC1026469     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  7 in total

1.  Modification of pulmonary oxygen toxicity by bleomycin treatment.

Authors:  S Matalon; W V Harper; J M Goldinger; P A Nickerson; J Olszowka
Journal:  J Appl Physiol (1985)       Date:  1985-06

2.  Pulmonary complications associated with combination chemotherapy programs containing bleomycin.

Authors:  K A Bauer; A T Skarin; J P Balikian; M B Garnick; D S Rosenthal; G P Canellos
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

3.  The pulmonary toxicity of antineoplastic agents.

Authors:  S J Ginsberg; R L Comis
Journal:  Semin Oncol       Date:  1982-03       Impact factor: 4.929

4.  Activity and toxicity of bleomycin.

Authors:  M Ishizuka; H Takayama; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1967-01       Impact factor: 2.649

Review 5.  Drug-induced pulmonary disease. Part 1: Cytotoxic drugs.

Authors:  J A Cooper; D A White; R A Matthay
Journal:  Am Rev Respir Dis       Date:  1986-02

6.  Pulmonary involvement in rheumatoid arthritis.

Authors:  P Cervantes-Perez; A H Toro-Perez; P Rodriguez-Jurado
Journal:  JAMA       Date:  1980-05-02       Impact factor: 56.272

Review 7.  Cytotoxic drug-induced pulmonary disease: update 1980.

Authors:  R B Weiss; F M Muggia
Journal:  Am J Med       Date:  1980-02       Impact factor: 4.965
  7 in total
  2 in total

Review 1.  Molecular Mechanisms of Alveolar Epithelial Stem Cell Senescence and Senescence-Associated Differentiation Disorders in Pulmonary Fibrosis.

Authors:  Xiaojing Hong; Lihui Wang; Kexiong Zhang; Jun Liu; Jun-Ping Liu
Journal:  Cells       Date:  2022-03-03       Impact factor: 6.600

2.  Successful treatment of methotrexate-associated classical Hodgkin lymphoma with brentuximab vedotin-combined chemotherapy: a case series.

Authors:  Satoshi Ichikawa; Noriko Fukuhara; Kei Saito; Koichi Onodera; Tsuyoshi Shirai; Yasushi Onishi; Hisayuki Yokoyama; Hiroshi Fujii; Ryo Ichinohasama; Hideo Harigae
Journal:  Int J Hematol       Date:  2020-01-18       Impact factor: 2.319
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.